Skip to content
<title>Channels - Optimization of DADA2 in QIIME2 for improving fidelity in 16S rRNA V4 amplicon data analysis :: FRELIP Discovery
-
PCR bias in 16S rRNA genes caused by GC content leads to insufficient detection of some abundant species in amplicon sequencing analyses of thermophilic microbial communities
-
16S rRNA gene copy number variation and sink biomass shape source contributions in community-wide microbial source tracking
-
Exploring infant gut–derived probiotics through 16S rRNA identification and in vitro functional characterization
-
Towards quantitative metabarcoding of eukaryotic plankton: an approach to improve 18S rRNA gene copy number bias
-
Species-level profiling of Landoltia punctata (duckweed) microbiome under nutrient stress using full-length 16S rRNA sequencing
-
Mitochondrial Markers COI and 16S rRNA for the Molecular Identification of Parrots and Macaws Recovered From Illegal Trafficking in Three Areas of Colombia
-
18S rDNA amplicon sequence data (V1–V3) of the Palmyra Atoll National Wildlife Refuge, Central Pacific
-
Natrix2 – Improved amplicon workflow with novel Oxford Nanopore Technologies support and enhancements in clustering, classification and taxonomic databases
-
Evaluation of RNA extraction and rRNA depletion protocols for RNA-Seq in eleven edible seaweed species from brown, red, and green algae
-
Association analysis of Mycoplasma pneumoniae 23S rRNA gene mutation with refractory Mycoplasma pneumoniae pneumonia in children
-
Identification of pathogenic fungi causing ocular infections using full rRNA operon sequencing with Oxford Nanopore Technologies
-
V. 1, No. 2
-
V. 2, No. 3
-
ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability
-
Constraining lake ecology via metagenomics, metatranscriptomics, and amplicon sequencing
-
Volume 16, no 2/2024
-
Maskay Vol. 16 No. 2
-
A targeted amplicon sequencing panel for cost-effective high-throughput genotyping of
-
MIRit: an integrative R framework for the identification of impaired miRNA–mRNA regulatory networks in complex diseases
-
Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariant
-
Table of Contents (v. 16, no. 3)
-
Inhibiting Effect of Medical Compounds for SARS-CoV-2 and Secretory Phospholipase A2
-
Cover & Contents Vol.16 No.2
-
Preface MEV Vol 16 Iss 2
